Contraception blood-clot risk: ‘public need better access to advice’

Contraception blood-clot risk: ‘public need better access to advice’

The Guardian

.

.
.
.

Health experts in UK say risk remains low, as social media debates shift from AstraZeneca jab to hormonal contraceptives

Women need more information about contraceptive options, experts said, after concerns over rare blood clots linked to the AstraZeneca Covid jab prompted a debate over side-effects caused by certain forms of the pill.

On Wednesday the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said that evidence that the jab could be causing a rare blood clotting syndrome was growing stronger. As a result the UK’s Joint Committee on Vaccination and Immunisation (JCVI) recommended that healthy people under the age of 30 who were at low risk of Covid should be offered a different vaccine if possible.

Continue reading…